- Trials with a EudraCT protocol (74)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
74 result(s) found for: Infertility AND IVF.
Displaying page 2 of 4.
EudraCT Number: 2018-001137-41 | Sponsor Protocol Number: 666 | Start Date*: 2018-06-26 |
Sponsor Name:Hvidovre Hospital. Dep of Respiratory Medicine | ||
Full Title: Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the sixth day o... | ||
Medical condition: infertility within female asthma patients as a result of systemic inflamation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002385-31 | Sponsor Protocol Number: 2015/582 | Start Date*: 2017-08-28 | |||||||||||
Sponsor Name:Professor Peter Humaidan, The Fertility Clinic Skive | |||||||||||||
Full Title: A double-blind, placebo-controlled multicenter trial on the effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002267-18 | Sponsor Protocol Number: APTE | Start Date*: 2017-11-27 | ||||||||||||||||||||||||||
Sponsor Name:Sara Rafael Fernández | ||||||||||||||||||||||||||||
Full Title: EFFICACY AND SAFETY OF THE CONCENTRATE OF AUTOMOTIVE RICH PLASMA IN GROWTH FACTORS IN THE TREATMENT OF THE FINE ENDOMETRY IN PATIENTS SUBMITTED TO TRANSFER OF CRIO-PRESERVED EMBRYOS: CLINICAL TRIAL... | ||||||||||||||||||||||||||||
Medical condition: infertile women | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000689-13 | Sponsor Protocol Number: HRT1vs2week.2018 | Start Date*: 2018-07-11 | |||||||||||
Sponsor Name:University hospital Brussel | |||||||||||||
Full Title: Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002783-40 | Sponsor Protocol Number: 000304 | Start Date*: 2019-07-04 | |||||||||||||||||||||||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
Full Title: A randomised, controlled, open label, parallel group, multicentre trial comparing the efficacy and safety of individualised FE 999049 (follitropin delta) dosing, using a long GnRH agonist protocol ... | |||||||||||||||||||||||||||||||||
Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) DK (Completed) NO (Completed) NL (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003788-67 | Sponsor Protocol Number: FS1306 | Start Date*: 2014-01-29 | |||||||||||
Sponsor Name:Watson Laboratories, Inc. - A subsidiary of Actavis, Inc. | |||||||||||||
Full Title: A Randomised, Parallel Group, Assessor-Blind, Multicentre Study to Compare the Safety and Efficacy of Watson rhFSH with Follitropin Alfa (GONAL-f) in Stimulating Multiple Follicular Development in ... | |||||||||||||
Medical condition: Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006595-11 | Sponsor Protocol Number: 07EU/Prg06 | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:IBSA Institut Biochimique SA | |||||||||||||
Full Title: Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF). | |||||||||||||
Medical condition: Patient undergoing in-Vitro Fertilization (IVF) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023534-23 | Sponsor Protocol Number: EMR 200061-504 | Start Date*: 2011-05-09 | ||||||||||||||||
Sponsor Name:Merck Serono S.A. - Geneva | ||||||||||||||||||
Full Title: A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 ... | ||||||||||||||||||
Medical condition: Fertility disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Completed) SK (Completed) DE (Completed) FI (Completed) GB (Completed) DK (Completed) GR (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002482-19 | Sponsor Protocol Number: 13EU/FSH01 | Start Date*: 2013-12-12 | |||||||||||
Sponsor Name:IBSA Institut Biochimique S.A. | |||||||||||||
Full Title: Randomised clinical trial comparing highly purified FSH formulation (Fostimon®) and recombinant FSH (Gonal-F®) in GnRH-antagonist controlled ovarian hyperstimulation cycles. | |||||||||||||
Medical condition: female infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) ES (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003856-31 | Sponsor Protocol Number: BER-LUT-2015-02 | Start Date*: 2015-12-04 | |||||||||||
Sponsor Name:INSTITUTO BERNABEU | |||||||||||||
Full Title: EARLY FOLLICULAR PHASE vs LUTHEAL PHASE OVARIAN STIMULATION IN BOLOGNA CRITERIA IVF/ICSI CYCLES: A RANDOMIZED COMPARATIVE SINGLE CENTER TRIAL. LUTEAL TRIAL | |||||||||||||
Medical condition: Patients with diagnosis of low response (Bologna criteria) and who perform ovarian stimulation for accumulation of vitrified oocytes. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001785-38 | Sponsor Protocol Number: 000401 | Start Date*: 2021-10-05 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response of a starting dose of 15 µg follitropin delta (REKOVELLE) to a starting do... | |||||||||||||
Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Completed) FR (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012666-31 | Sponsor Protocol Number: OG09/8956 | Start Date*: 2009-11-11 | |||||||||||
Sponsor Name:Leeds Teaching Hospitals and University of Leeds | |||||||||||||
Full Title: The role of progesterone support and genetic polymorphisms for inflammatory cytokines on the risk of developing ovarian hyperstimulation syndrome (OHSS) in women undergoing In-Vitro fertilisation/I... | |||||||||||||
Medical condition: Ovarian Hyperstimulation syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002040-24 | Sponsor Protocol Number: FI028.DEX001.2019 | Start Date*: 2020-04-14 |
Sponsor Name:Dextra fertility clinic [...] | ||
Full Title: Iron defiency as an ignored cause of infertility | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002679-34 | Sponsor Protocol Number: 1-2005 | Start Date*: 2005-11-02 |
Sponsor Name:The Fertility Clinic, Sygehus Viborg (Skive) | ||
Full Title: The effect of LH priming in early follicular phase on the endocrinological function of the ovary and pregnancy rate in GnRh downregulated women stimulated by exogen gonadotophins in IVF-treatment | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001143-59 | Sponsor Protocol Number: IVFAFC1 | Start Date*: 2006-07-14 |
Sponsor Name:School of Human Development | ||
Full Title: A prospective, randomised study comparing two fixed daily doses (150 IU versus 225 IU) of recombinant FSH for ovarian stimulation during in-vitro fertilisation treatment in predicted low and interm... | ||
Medical condition: Infertility needing In-Vitro fertilisation treatment | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-001259-22 | Sponsor Protocol Number: 28613 | Start Date*: 2008-09-01 | |||||||||||
Sponsor Name:Merck Serono International S.A. | |||||||||||||
Full Title: A phase IV prospective, multicentre, randomized, open-label trial to assess the efficacy and safety of GONAL f® at a dose based on subject baseline characteristics determined according to the CONSO... | |||||||||||||
Medical condition: Ovarian stimulation in women undergoing assisted reproductive technology | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) SE (Completed) ES (Completed) DE (Completed) DK (Completed) GB (Completed) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001069-35 | Sponsor Protocol Number: IIBSP-EDA-2020-18 | Start Date*: 2021-07-06 |
Sponsor Name:Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau | ||
Full Title: Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study. | ||
Medical condition: Cumulative live-birth rate. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000753-80 | Sponsor Protocol Number: 000298 | Start Date*: 2022-08-04 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005452-24 | Sponsor Protocol Number: KvL | Start Date*: 2008-10-30 | |||||||||||
Sponsor Name:Fertilitetsklinikken, Afsnit 455, Gynækologisk-Obstetrisk Afdeling, Hvidovre Hospital | |||||||||||||
Full Title: Kort versus lang reagensglasbehandling. En prospektiv, konsekutiv og randomiseret sammenlignende undersøgelse. | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004114-99 | Sponsor Protocol Number: FERTIRES-2016 | Start Date*: 2017-05-18 |
Sponsor Name:AB-BIOTICS | ||
Full Title: USE OF P.N680S POLYMORPHISM TO CHOOSE THE EXOGEN FSH DOSE IN CONTROLLED OVARIAN HYPERSTIMULATION: A PROSPECTIVE TRIAL | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
